RE:Trading on the 15thI'm wondering the same. The additional shares aren't showing in the share count yet. It seems it's: a bought deal financing (unlikely with no NR); partner buying shares ahead of deal. (Incidentally the future increase in S/P alone could pay for trials on its own) ; an investor providing trial funding. (Seems most likely IF a partner won't step up yet. Company basically saying if you won't pay us what we want we will go it alone a bit longer)
No matter what it was, regulatory flings by the purchaser should be forthcoming.